21.02.2014 Views

A reproductive health needs assessment in Myanmar

A reproductive health needs assessment in Myanmar

A reproductive health needs assessment in Myanmar

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A Reproductive Health Needs Assessment <strong>in</strong> <strong>Myanmar</strong><br />

Table 9. Per cent of currently married women of <strong>reproductive</strong> age who are currently us<strong>in</strong>g a<br />

birth spac<strong>in</strong>g method (per cent of current contraceptive users who are us<strong>in</strong>g a specific birth<br />

spac<strong>in</strong>g method)<br />

1991 PCFS 1997 FRHS<br />

Pill 4.0 (23.8) 7.4 (22.8)<br />

Injecton 3.1 (18.5) 11.7 (36.0)<br />

I U D 0.9 (5.4) 1.3 (4.0)<br />

Condom 0.1 (0.6) 0.1 (0.3)<br />

Female sterilisation 3.7 (22.0) 5.5 (16.9)<br />

Male sterilisation 1.8 (10.7) 2.2 (6.8)<br />

Traditional methods 3.2 (19.0) 4.3 (13.2)<br />

Total 16.8 (100) 32.7 (100)<br />

Source: M<strong>in</strong>istry of Immigration and Population (1998) Fertility and Reproductive Health<br />

Survey (prelim<strong>in</strong>ary results), and M<strong>in</strong>istry of Immigration and Population (1995) <strong>Myanmar</strong><br />

Population Changes and Fertility Survey.<br />

Hormonal methods<br />

The extent of the use of hormonal methods has been well documented <strong>in</strong> a number of recent<br />

studies (see M<strong>in</strong>istry of Health 1997a). The f<strong>in</strong>d<strong>in</strong>gs from the current <strong>assessment</strong> confirm<br />

much of what was already known, particularly that both pills and <strong>in</strong>jectables are widely<br />

preferred throughout <strong>Myanmar</strong>. One new f<strong>in</strong>d<strong>in</strong>g from this <strong>assessment</strong> is that the use of<br />

<strong>in</strong>jectables appears to be <strong>in</strong>creas<strong>in</strong>g, and <strong>in</strong> many places they are now more popular than pills.<br />

This also corroborates the FRHS f<strong>in</strong>d<strong>in</strong>gs. There are many types and brands of <strong>in</strong>jectables on<br />

the market and <strong>in</strong> use, <strong>in</strong>clud<strong>in</strong>g one-monthly Ch<strong>in</strong>ese <strong>in</strong>jectables, two monthly (Noristerate)<br />

and three-monthly (DMPA) <strong>in</strong>jections. Similarly, there are several brands of oral<br />

contraceptive pills available.<br />

From discussions with community members and service providers, the team found that there<br />

had been a considerable decrease <strong>in</strong> the use of two specific hormonal methods made <strong>in</strong> Ch<strong>in</strong>a,<br />

the once-a-month Ch<strong>in</strong>ese <strong>in</strong>jectable and the once-a-month pill. Dur<strong>in</strong>g the WHO sponsored<br />

Assessment of the Contraceptive Method Mix conducted <strong>in</strong> 1996, the use of these methods<br />

was reportedly high, and was identified as a cause for concern (M<strong>in</strong>istry of Health 1997).<br />

Many providers dur<strong>in</strong>g the current <strong>assessment</strong> seemed to be aware of the low efficacy and<br />

possible harmful effects of these methods. Providers reported, however, that some women<br />

use them because of their low cost.<br />

Female sterilisation<br />

As noted above, female sterilisation is the only method available <strong>in</strong> the public sector <strong>in</strong><br />

townships without a birth spac<strong>in</strong>g programme. In the 1997 FRHS 17 per cent of currently<br />

contracept<strong>in</strong>g married women of <strong>reproductive</strong> age were found to rely on female sterilisation,<br />

represent<strong>in</strong>g 5.5 per cent of the total currently married women of <strong>reproductive</strong> age. One<br />

provider reported that the popularity of sterilisation was on the <strong>in</strong>crease. In terms of per cent<br />

of currently married women, this appears to be true from the PCFS and FRHS data presented<br />

above (Table 9), but the relative prom<strong>in</strong>ence of this method <strong>in</strong> the overall method mix has<br />

somewhat decreased.<br />

The method is only available to women who have been given specific permission.<br />

Application for sterilisation <strong>in</strong>volves the submission of a form signed by the woman, her<br />

33

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!